Non‐steroidal anti‐inflammatory drug‐induced cardiovascular adverse events: a meta‐analysis
BR Gunter, KA Butler, RL Wallace… - Journal of clinical …, 2017 - Wiley Online Library
What is known and objective Although non‐steroidal anti‐inflammatory drugs (NSAID s)
have been studied in randomized, controlled trials and meta‐analyses in an effort to …
have been studied in randomized, controlled trials and meta‐analyses in an effort to …
Cardiovascular risk of nonsteroidal anti‐inflammatory drugs and classical and selective cyclooxygenase‐2 inhibitors: a meta‐analysis of observational studies
LH Martín Arias, A Martín González… - The journal of …, 2019 - Wiley Online Library
The purpose of this study was to review the published evidence on the clinical use of
nonsteroidal anti‐inflammatory drugs (NSAIDs) and to assess the cardiovascular risk (CVR) …
nonsteroidal anti‐inflammatory drugs (NSAIDs) and to assess the cardiovascular risk (CVR) …
An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs
ME Farkouh, BP Greenberg - The American journal of cardiology, 2009 - Elsevier
Nonsteroidal anti-inflammatory drugs (NSAIDs), both nonselective and cyclooxygenase-2–
specific inhibitors, are commonly used medications for the relief of acute and chronic pain …
specific inhibitors, are commonly used medications for the relief of acute and chronic pain …
Cardiovascular adverse effects of anti-inflammatory drugs
C Roubille, J Martel-Pelletier, JM Davy… - Anti-Inflammatory & …, 2013 - ingentaconnect.com
Anti-inflammatory drugs consist of non-steroidal anti-inflammatory drugs (NSAIDs) including
non-selective nsNSAIDs, aspirin, and cyclooxygenase-2 (COX-2)-selective inhibitors also …
non-selective nsNSAIDs, aspirin, and cyclooxygenase-2 (COX-2)-selective inhibitors also …
Risk of myocardial infarction and death associated with the use of nonsteroidal anti‐inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort …
EL Fosbøl, GH Gislason, S Jacobsen… - Clinical …, 2009 - Wiley Online Library
Use of some nonsteroidal anti‐inflammatory drugs (NSAIDs) is associated with increased
cardiovascular risk in several patient groups, but whether this excess risk exists in …
cardiovascular risk in several patient groups, but whether this excess risk exists in …
[HTML][HTML] Cardiovascular risk of nonsteroidal anti-inflammatory drugs: an under-recognized public health issue
Z Varga, S rafay ali Sabzwari, V Vargova - Cureus, 2017 - ncbi.nlm.nih.gov
Nonsteroidal anti-inflammatory drugs (NSAIDs) are drugs with analgesic, anti-inflammatory,
and antipyretic activity. Their effect is achieved by the reduction in synthesis of prostanoids …
and antipyretic activity. Their effect is achieved by the reduction in synthesis of prostanoids …
Nonsteroidal anti-inflammatory drugs and cardiovascular safety–translating pharmacological data into clinical readouts
S Tacconelli, A Bruno, R Grande… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: The pharmacological management of pain includes the use of nonsteroidal anti-
inflammatory drugs (NSAIDs). They comprise traditional (t) NSAIDs and selective …
inflammatory drugs (NSAIDs). They comprise traditional (t) NSAIDs and selective …
Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials
WB White, CR West, JS Borer, PB Gorelick… - The American journal of …, 2007 - Elsevier
Some nonsteroidal anti-inflammatory drugs (NSAIDs), including cyclooxygenase-2 selective
inhibitors, have been associated with increased cardiovascular (CV) events in recent clinical …
inhibitors, have been associated with increased cardiovascular (CV) events in recent clinical …
Cardiovascular effects and safety of (non-aspirin) NSAIDs
AM Schjerning, P McGettigan, G Gislason - Nature Reviews Cardiology, 2020 - nature.com
Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective, widely used analgesics. For
the past 2 decades, considerable attention has been focused on their cardiovascular safety …
the past 2 decades, considerable attention has been focused on their cardiovascular safety …
Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications
A Fanelli, D Ghisi, PL Aprile… - Therapeutic advances in …, 2017 - journals.sagepub.com
Observational studies and meta-analyses have shown that the administration of
nonsteroidal anti-inflammatory drugs (NSAIDs), especially when prescribed at high doses …
nonsteroidal anti-inflammatory drugs (NSAIDs), especially when prescribed at high doses …